CRBU
Price
$1.92
Change
-$0.15 (-7.25%)
Updated
Jun 5 closing price
Capitalization
190.43M
65 days until earnings call
Intraday BUY SELL Signals
PRME
Price
$3.06
Change
-$0.41 (-11.82%)
Updated
Jun 5 closing price
Capitalization
552.69M
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBU vs PRME

Header iconCRBU vs PRME Comparison
Open Charts CRBU vs PRMEBanner chart's image
CRBU vs PRME Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRBU vs. PRME commentary
Jun 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and PRME is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2026
Stock price -- (CRBU: $1.92 vs. PRME: $3.06)
Brand notoriety: CRBU and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 104% vs. PRME: 191%
Market capitalization -- CRBU: $190.43M vs. PRME: $552.69M
CRBU [@Biotechnology] is valued at $190.43M. PRME’s [@Biotechnology] market capitalization is $552.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.41B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 4 TA indicator(s) are bullish while PRME’s TA Score has 5 bullish TA indicator(s).

  • CRBU’s TA Score: 4 bullish, 6 bearish.
  • PRME’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PRME is a better buy in the short-term than CRBU.

Price Growth

CRBU (@Biotechnology) experienced а -18.64% price change this week, while PRME (@Biotechnology) price change was -13.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.86%. For the same industry, the average monthly price growth was -7.98%, and the average quarterly price growth was -1.75%.

Reported Earning Dates

CRBU is expected to report earnings on Aug 11, 2026.

PRME is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-7.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($553M) has a higher market cap than CRBU($190M). CRBU YTD gains are higher at: 20.755 vs. PRME (-11.816). CRBU has higher annual earnings (EBITDA): -116.43M vs. PRME (-199.14M). PRME has more cash in the bank: 135M vs. CRBU (118M). CRBU has less debt than PRME: CRBU (26.9M) vs PRME (115M). CRBU has higher revenues than PRME: CRBU (11.2M) vs PRME (4.03M).
CRBUPRMECRBU / PRME
Capitalization190M553M34%
EBITDA-116.43M-199.14M58%
Gain YTD20.755-11.816-176%
P/E RatioN/AN/A-
Revenue11.2M4.03M278%
Total Cash118M135M87%
Total Debt26.9M115M23%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
29

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUPRME
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signal:
Gain/Loss:
PRME
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IACIX12.29N/A
N/A
VY® American Century Sm-Mid Cp Val I
TSEGX20.87N/A
N/A
Touchstone Sands Cptl Emerg Mkts Gr Inst
WEEIX10.46-0.10
-0.95%
TETON Westwood Equity I
SCVEX23.48-0.75
-3.10%
Hartford Schroders International Stk A
LICFX20.24-0.99
-4.66%
Lord Abbett International Equity F

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with BEAM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
-11.82%
BEAM - PRME
60%
Loosely correlated
-10.48%
CRSP - PRME
58%
Loosely correlated
-8.97%
RXRX - PRME
57%
Loosely correlated
-12.76%
CRBU - PRME
52%
Loosely correlated
-7.02%
EDIT - PRME
51%
Loosely correlated
-9.36%
More